A Rare Case of Factor VII Inhibitor in a Patient Presenting with Primary Splenic Marginal Zone Lymphoma

Kendra Naismith; Pat A. Allevato; Caroline Hamm

doi:10.12659/AJCR.932704

06 September 2021 : Case report Canada

A Rare Case of Factor VII Inhibitor in a Patient Presenting with Primary Splenic Marginal Zone Lymphoma

Rare disease

Kendra Naismith^1CDEF, Pat A. Allevato^2B, Caroline Hamm^13ABDF*

DOI: 10.12659/AJCR.932704

Am J Case Rep 2021; 22:e932704

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 2. Plot of international normalized ratio (INR) and platelet counts. INR and platelet counts displayed over the first 2 months after initial presentation. The dashed lines indicated the first 2 rituximab treatments.

Back to the Article

A Rare Case of Factor VII Inhibitor in a Patient Presenting with Primary Splenic Marginal Zone Lymphoma

Your Privacy